0001228924-21-000082.txt : 20211210 0001228924-21-000082.hdr.sgml : 20211210 20211210191418 ACCESSION NUMBER: 0001228924-21-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211210 FILED AS OF DATE: 20211210 DATE AS OF CHANGE: 20211210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sakys John CENTRAL INDEX KEY: 0001197710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11740 FILM NUMBER: 211486632 MAIL ADDRESS: STREET 1: MESA LABORATORIES, INC. STREET 2: 12100 W. 6TH AVENUE CITY: LAKEWOOD STATE: CO ZIP: 80228 FORMER NAME: FORMER CONFORMED NAME: SAKYS JOHN V DATE OF NAME CHANGE: 20021010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MESA LABORATORIES INC /CO/ CENTRAL INDEX KEY: 0000724004 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 840872291 STATE OF INCORPORATION: CO FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 12100 W 6TH AVE CITY: LAKEWOOD STATE: CO ZIP: 80228 BUSINESS PHONE: 3039878000 MAIL ADDRESS: STREET 1: 12100 W 6TH AVE CITY: LAKEWOOD STATE: CO ZIP: 80228 FORMER COMPANY: FORMER CONFORMED NAME: MESA LABORATORIES INC /CO DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: MESA MEDICAL INC DATE OF NAME CHANGE: 19921123 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-12-10 0 0000724004 MESA LABORATORIES INC /CO/ MLAB 0001197710 Sakys John MESA LABORATORIES, INC. 12100 W. 6TH AVENUE LAKEWOOD CO 80228 0 1 0 0 CFO Common Stock 2021-12-10 4 M 0 158 89.7 A 7672 D Common Stock 2021-12-10 4 M 0 1600 97.78 A 9272 D Common Stock 2021-12-10 4 S 0 1758 324.74 D 7514 D Incentive Stock Option 89.7 2021-12-10 4 X 0 158 0 D 2015-04-01 2022-04-01 Common Stock 158 29871 D Non Qualified Stock Option 97.78 2021-12-10 4 X 0 1600 0 D 2017-04-01 2022-04-01 Common Stock 1600 28271 D 1/7 exercisable on each anniversary date of the 04/01/2014 grant date 1/5 exercisable on each anniversary date of the 04-01-2016 grant date Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on March 1, 2021 John Sakys 2021-12-10